Helicobacter species infection may be associated with cholangiocarcinoma: A meta-analysis

International Journal of Clinical Practice

Volumn 68, Issue 2, 2014, Pages 262-270

  Xiao, M ^a,b   Gao, Y ^a   Wang, Y ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b WUXI PEOPLE S HOSPITAL AFFILIATED TO NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BILE DUCT CARCINOMA; BILE DUCT TUMOR; COMPLICATION; EPIDEMIOLOGY; HELICOBACTER; HELICOBACTER INFECTION; HUMAN; INTRAHEPATIC BILE DUCT; ISOLATION AND PURIFICATION; META ANALYSIS; MICROBIOLOGY;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; EPIDEMIOLOGIC METHODS; HELICOBACTER; HELICOBACTER INFECTIONS; HUMANS;

EID: 84893687147     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/ijcp.12264     Document Type: Article

References (64)

1. Khan SA, Davidson BR, Goldin RD, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut 2012; 61: 1657-69.
2. Randi G, Franceschi S, La Vecchia C,. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 2006; 118: 1591-602.
3. Patel T,. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer 2002; 2: 10.
4. Khan SA, Emadossadaty S, Ladep NG, et al. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us? J Hepatol 2012; 56: 848-54.
5. Castro FA, Koshiol J, Hsing AW, et al. Inflammatory gene variants and the risk of biliary tract cancers and stones: a population-based study in China. BMC Cancer 2012; 12: 468.
6. Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 2010; 362: 1273-81.
7. Patel T,. Cholangiocarcinoma-controversies and challenges. Nat Rev Gastroenterol Hepatol 2011; 8: 189-200.
8. Zatonski WA, Lowenfels AB, Boyle P, et al. Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer. J Natl Cancer Inst 1997; 89: 1132-8.
9. Smout MJ, Sripa B, Laha T, et al. Infection with the carcinogenic human liver fluke, Opisthorchis viverrini. Mol BioSyst 2011; 7: 1367-75.
10. Chapman RW,. Risk factors for biliary tract carcinogenesis. Ann Oncol 1999; 10 (Suppl. 4): 308-11.
11. Marshall BJ, Warren JR,. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311-5.
12. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-31.
13. An international association between Helicobacter pylori infection and gastric cancer. The EUROGAST Study Group. Lancet 1993; 341: 1359-62.
14. Moeller H, Correa P,. Carcinogenicity of some biological agents. Cancer Epidemiol Biomarkers Prev 1994; 3: 627.
15. Roe IH, Kim JT, Lee HS, Lee JH,. Detection of Helicobacter DNA in bile from bile duct diseases. J Korean Med Sci 1999; 14: 182-6.
16. Nilsson HO, Mulchandani R, Tranberg KG, Stenram U, Wadstrom T,. Helicobacter species identified in liver from patients with cholangiocarcinoma and hepatocellular carcinoma. Gastroenterology 2001; 120: 323-4.
17. Ward JM, Anver MR, Haines DC, Benveniste RE,. Chronic active hepatitis in mice caused by Helicobacter hepaticus. Am J Pathol 1994; 145: 959-68.
18. Hamada T, Yokota K, Ayada K, et al. Detection of Helicobacter hepaticus in human bile samples of patients with biliary disease. Helicobacter 2009; 14: 545-51.
19. Fox JG, Li X, Yan L, et al. Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: a model of helicobacter-induced carcinogenesis. Infect Immun 1996; 64: 1548-58.
20. Fox JG, Dewhirst FE, Shen Z, et al. Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology 1998; 114: 755-63.
21. Avenaud P, Marais A, Monteiro L, et al. Detection of Helicobacter species in the liver of patients with and without primary liver carcinoma. Cancer 2000; 89: 1431-9.
22. Pandey M, Mishra RR, Dixit R, Jaiswal R, Shukla M, Nath G,. Helicobacter bilis in human gallbladder cancer: results of a case-control study and a meta-analysis. Asian Pac J Cancer Prev 2010; 11: 343-7.
23. Bulajic M, Maisonneuve P, Schneider-Brachert W, et al. Helicobacter pylori and the risk of benign and malignant biliary tract disease. Cancer 2002; 95: 1946-53.
24. Mishra RR, Tewari M, Shukla HS,. Helicobacter pylori and pathogenesis of gallbladder cancer. J Gastroenterol Hepatol 2011; 26: 260-6.
25. Murata H, Tsuji S, Tsujii M, et al. Helicobacter bilis infection in biliary tract cancer. Aliment Pharmacol Ther 2004; 20 (Suppl. 1): 90-4.
26. Bohr UR, Kuester D, Meyer F, et al. Low prevalence of Helicobacteraceae in gall-stone disease and gall-bladder carcinoma in the German population. Clin Microbiol Infect 2007; 13: 525-31.
27. Fukuda K, Kuroki T, Tajima Y, et al. Comparative analysis of Helicobacter DNAs and biliary pathology in patients with and without hepatobiliary cancer. Carcinogenesis 2002; 23: 1927-31.
28. Zhou D, Zhang Y, Gong W, et al. Are Helicobacter pylori and other Helicobacter species infection associated with human biliary lithiasis? A meta-analysis PLoS ONE 2011; 6: e27390.
29. Leong RW,. Differences in peptic ulcer between the East and the West. Gastroenterol Clin North Am 2009; 38: 363-79.
30. Pandey M, Shukla M,. Helicobacter species are associated with possible increase in risk of hepatobiliary tract cancers. Surg Oncol 2009; 18: 51-6.
31. Shimoyama T, Takahashi R, Abe D, Mizuki I, Endo T, Fukuda S,. Serological analysis of Helicobacter hepaticus infection in patients with biliary and pancreatic diseases. J Gastroenterol Hepatol 2010; 25 (Suppl. 1): S86-9.
32. Yakoob J, Khan MR, Abbas Z, et al. Helicobacter pylori: association with gall bladder disorders in Pakistan. Br J Biomed Sci 2011; 68: 59-64.
33. Karagin PH, Stenram U, Wadstrom T, Ljungh A,. Helicobacter species and common gut bacterial DNA in gallbladder with cholecystitis. World J Gastroenterol 2010; 16: 4817-22.
34. Rossi M, Hanninen ML,. Helicobacter spp. other than H. pylori. Helicobacter 2012; 17 (Suppl. 1): 56-61.
35. Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents. IARC Sci Publ 2008; 1-837.
36. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF,. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement QUOROM Group. Br J Surg 2000; 87: 1448-54.
37. Stang A,. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25: 603-5.
38. Abu Al-Soud W, Stenram U, Ljungh A, Tranberg KG, Nilsson HO, Wadstrom T,. DNA of Helicobacter spp. and common gut bacteria in primary liver carcinoma. Dig Liver Dis 2008; 40: 126-31.
39. Kobayashi T, Harada K, Miwa K, Nakanuma Y,. Helicobacter genus DNA fragments are commonly detectable in bile from patients with extrahepatic biliary diseases and associated with their pathogenesis. Dig Dis Sci 2005; 50: 862-7.
40. Chen H, Chen Y,. Helicobacter-specific 16S ribosomal DNA identified from patients with cholangiocarcinoma. Chin J Gen Surg 2003; 12: 27-9.
41. Boonyanugomol W, Chomvarin C, Sripa B, et al. Helicobacter pylori in Thai patients with cholangiocarcinoma and its association with biliary inflammation and proliferation. HPB (Oxford) 2012; 14: 177-84.
42. Matsukura N, Yokomuro S, Yamada S, et al. Association between Helicobacter bilis in bile and biliary tract malignancies: H. bilis in bile from Japanese and Thai patients with benign and malignant diseases in the biliary tract. Jpn J Cancer Res 2002; 93: 842-7.
43. Pellicano R, Menard A, Rizzetto M, Megraud F,. Helicobacter species and liver diseases: association or causation? Lancet Infect Dis 2008; 8: 254-60.
44. Verhoef C, Pot RG, de Man RA, et al. Detection of identical Helicobacter DNA in the stomach and in the non-cirrhotic liver of patients with hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2003; 15: 1171-4.
45. Ito K, Nakamura M, Toda G, Negishi M, Torii A, Ohno T,. Potential role of Helicobacter pylori in hepatocarcinogenesis. Int J Mol Med 2004; 13: 221-7.
46. Hatakeyama M,. Helicobacter pylori and gastric carcinogenesis. J Gastroenterol 2009; 44: 239-48.
47. Wang G, Gao F, Zhang W, et al. Involvement of Aquaporin 3 in Helicobacter pylori-related gastric diseases. PLoS ONE 2012; 7: e49104.
48. Pai R, Cover TL, Tarnawski AS,. Helicobacter pylori vacuolating cytotoxin (VacA) disorganizes the cytoskeletal architecture of gastric epithelial cells. Biochem Biophys Res Commun 1999; 262: 245-50.
49. Oswald E, Nougayrede JP, Taieb F, Sugai M,. Bacterial toxins that modulate host cell-cycle progression. Curr Opin Microbiol 2005; 8: 83-91.
50. Tonkic A, Tonkic M, Lehours P, Megraud F,. Epidemiology and diagnosis of Helicobacter pylori infection. Helicobacter 2012; 17 (Suppl. 1): 1-8.
51. Srivatanakul P, Sriplung H, Deerasamee S,. Epidemiology of liver cancer: an overview. Asian Pac J Cancer Prev 2004; 5: 118-25.
52. On SL,. Identification methods for campylobacters, helicobacters, and related organisms. Clin Microbiol Rev 1996; 9: 405-22.
53. Ho SA, Hoyle JA, Lewis FA, et al. Direct polymerase chain reaction test for detection of Helicobacter pylori in humans and animals. J Clin Microbiol 1991; 29: 2543-9.
54. Clayton CL, Kleanthous H, Coates PJ, Morgan DD, Tabaqchali S,. Sensitive detection of Helicobacter pylori by using polymerase chain reaction. J Clin Microbiol 1992; 30: 192-200.
55. Uribe R, Fujioka T, Ito A, Nishizono A, Nasu M,. Sensitive detection of Helicobacter pylori in gastric aspirates by polymerase chain reaction. Kansenshogaku Zasshi 1998; 72: 114-22.
56. Engstrand L, Nguyen AM, Graham DY, el-Zaatari FA,. Reverse transcription and polymerase chain reaction amplification of rRNA for detection of Helicobacter species. J Clin Microbiol 1992; 30: 2295-301.
57. O'Toole PW, Logan SM, Kostrzynska M, Wadstrom T, Trust TJ,. Isolation and biochemical and molecular analyses of a species-specific protein antigen from the gastric pathogen Helicobacter pylori. J Bacteriol 1991; 173: 505-13.
58. Labigne A, Cussac V, Courcoux P,. Shuttle cloning and nucleotide sequences of Helicobacter pylori genes responsible for urease activity. J Bacteriol 1991; 173: 1920-31.
59. Lu L, Cao HD, Zeng HQ, et al. Recombinant Mycobacterium smegmatis mc(2)155 vaccine expressing outer membrane protein 26 kDa antigen affords therapeutic protection against Helicobacter pylori infection. Vaccine 2009; 27: 972-8.
60. Hammar M, Tyszkiewicz T, Wadstrom T, O'Toole PW,. Rapid detection of Helicobacter pylori in gastric biopsy material by polymerase chain reaction. J Clin Microbiol 1992; 30: 54-8.
61. Abayli B, Colakoglu S, Serin M, et al. Helicobacter pylori in the etiology of cholesterol gallstones. J Clin Gastroenterol 2005; 39: 134-7.
62. Azevedo NF, Almeida C, Cerqueira L, Dias S, Keevil CW, Vieira MJ,. Coccoid form of Helicobacter pylori as a morphological manifestation of cell adaptation to the environment. Appl Environ Microbiol 2007; 73: 3423-7.
63. Huang Y, Fan XG, Wang ZM, Zhou JH, Tian XF, Li N,. Identification of helicobacter species in human liver samples from patients with primary hepatocellular carcinoma. J Clin Pathol 2004; 57: 1273-7.
64. Simes RJ,. Publication bias: the case for an international registry of clinical trials. J Clin Oncol 1986; 4: 1529-41.